Article info
Letter
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
- Dr S Grover, Department of Ophthalmology, University of Florida, 580 West 8th Street, Tower 2, 3rd Floor, Jacksonville, FL 32209, USA; sgrover{at}jax.ufl.edu
Citation
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
Publication history
- Accepted June 4, 2008
- First published July 10, 2008.
Online issue publication
February 09, 2022
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group